FDA Inspection 668810 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on July 7, 2010 in Amityville, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 11 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 7, 2010
Fiscal Year
2010
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Amityville, NY (United States)

Citations

IDCFRDescription
1550721 CFR 111.27(a)(5)(i)Refrigerator, freezer - temperature recording device
1556221 CFR 111.260(l)(1)Batch record - quality control review; production
1564121 CFR 111.453Written procedures - holding
1564521 CFR 111.455(c)Hold - mix-up, contamination, deterioration
1572321 CFR 111.365(i)Metal, foreign material
1573221 CFR 111.365(a)Conditions, controls -protect; microorganisms, contamination
1574421 CFR 111.210(h)(2)Master manufacturing record - sampling, tests, examinations
1575421 CFR 111.210(a)Master manufacturing record - dietary ingredients
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586121 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
1595121 CFR 111.110(c)Quality control operations - tests, examinations; results